Redo AF Sub Study (of the Pure EP 2.0 Main Study)

Clinical trial NCT04964440 · COMPLETED

Trial details

NCT number: NCT04964440
Sponsor: BioSig Technologies, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation Recurrent

Start date: 2021-03-03
Primary completion: 2021-07-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.